Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
18.37
Oct 30 • 3:59 PM ET Dollar change-0.30 Percentage change(-1.61%)
Aftermarket Close
18.83
Aftermarket • 7:30 PM ET Dollar change+0.46 Percentage change(2.48%)
Oct 29, 8:32 PMStrong nuclear orders extend Mirion’s post-earnings rally 11% in Thursday’s regular session
Index
RUT
Market Cap
4.51B
Enterprise Value
5.38B
Income
29.00M
Sales
1.08B
Book/sh
7.27
Cash/sh
1.71
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3281
IPO
Aug 20, 2020
P/E
176.63
Forward P/E
27.75
PEG
1.41
P/S
4.18
P/B
2.53
P/C
10.76
P/FCF
26.36
EV/EBITDA
23.11
EV/Sales
4.99
Quick Ratio
2.49
Current Ratio
3.02
Debt/Eq
0.70
LT Debt/Eq
0.69
Option/Short
Yes / Yes
EPS (ttm)
0.10
EPS next Y
0.66
EPS next Q
0.21
EPS this Y
17.50%
EPS next Y
22.48%
EPS next 5Y
19.65%
EPS past 3/5Y
- -
Sales past 3/5Y
8.84% -
EPS Y/Y TTM
-2.62%
Sales Y/Y TTM
19.65%
EPS Q/Q
139.82%
Sales Q/Q
24.52%
Insider Own
5.84%
Insider Trans
0.08%
Inst Own
108.48%
Inst Trans
-0.60%
ROA
0.83%
ROE
1.60%
ROIC
0.96%
Gross Margin
38.72%
Oper. Margin
7.36%
Profit Margin
2.69%
SMA20
15.13%
SMA50
17.20%
SMA200
0.44%
Trades
Shs Outstand
239.73M
Shs Float
231.16M
52W High
30.28 -39.33%
52W Low
14.04 30.84%
Volatility
6.56% 5.02%
ATR (14)
0.83
RSI (14)
68.57
Beta
1.12
Rel Volume
1.61
Avg Volume
4.12M
Volume
6,627,922
Perf Week
24.04%
Perf Month
28.01%
Perf Quarter
17.16%
Perf Half Y
-6.42%
Perf YTD
-21.56%
Perf Year
-36.72%
Perf 3Y
165.85%
Perf 5Y
73.47%
Perf 10Y
-
Prev Close
18.67
Price
18.37
Change %
-1.61%
Consensus
Strong Buy
Avg. Price Target
$23.27
Implied Upside
+26.7%
Analysts10incl. previous ratings
Rating Distribution9 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 03, 2026Initiated
JEF logoJJefferies
Buy$20+8.9%
Jan 23, 2026Initiated
MS logoMMorgan Stanley
Equal-Weight$29+57.9%
Nov 25, 2025Initiated
EVR logoEEvercore ISI
Outperform$29+57.9%
Sep 26, 2025Initiated
JPM logoJJP Morgan
Overweight$28+52.4%
Aug 25, 2025Initiated
NNorthland Capital
Outperform$26+41.5%
Dec 19, 2024Initiated
RRobert W. Baird
Outperform$22+19.8%
Sep 26, 2024Initiated
RILY logoRB. Riley Securities
Buy$14-23.8%
May 26, 2023Resumed
C logoCCitigroup
Buy$11-40.1%
Mar 24, 2022Initiated
CCJS Securities
Market Outperform$13-29.2%
Nov 29, 2021Initiated
GS logoGGoldman
Buy$14-23.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schopfer BrianChief Financial OfficerSep 02 '26Buy15.6020,000312,000933,290Sep 02 04:10 PM
Moore Christopher A.Chief Accounting Officer (PAO)May 07 '26Sale19.648,400164,97622,157May 08 04:08 PM
CHRISTOPHER MOOREOfficerMay 07 '26Proposed Sale19.648,400164,976May 07 04:48 PM
Kingsley Lawrence DDirectorDec 10 '25Sale24.73350,0008,654,8003,509,075Dec 12 04:05 PM
Lawrence D Kingsley Revocable DirectorDec 10 '25Proposed Sale25.00350,0008,750,000Dec 10 02:53 PM
Kingsley Lawrence DDirectorNov 21 '25Sale23.83300,0007,148,4003,900,000Nov 21 04:06 PM
Lawrence D Kingsley Revocable DirectorNov 21 '25Proposed Sale23.75300,0007,125,000Nov 21 01:30 PM
Eloy LoicNuclear & Safety PresidentNov 11 '25Sale27.2445,0001,225,68397,770Nov 12 04:18 PM
Lee EmmanuelleChief Legal OfficerNov 10 '25Sale27.4112,500342,64284,640Nov 12 04:18 PM
EMMANUELLE LEEOfficerNov 10 '25Proposed Sale27.4512,500343,125Nov 10 04:35 PM
Schopfer BrianChief Financial OfficerNov 06 '25Sale27.65100,0002,765,420904,432Nov 10 04:15 PM
Schopfer BrianOfficerNov 06 '25Proposed Sale27.65100,0002,765,420Nov 06 04:06 PM
Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Nuclear and Safety, and Technologies segments. The Nuclear and Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.
FounderMr. Thomas D. Logan
CFO & Medical Group PresidentMr. Brian Schopfer
Executive VPMs. Emmanuelle Lee J.D.
Chief Human Resources OfficerMs. Alison Ulrich
Group President of Nuclear & Safety TechnologiesMr. Loic Eloy